Trial
NCT05956600
An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, Los Angeles
Collaborators
PoloMar Health LLC
Condition
Schizophrenia, Treatment-Resistant
Intervention
Amisulpride 50 MG
Why stopped
Action of PI. Loss of sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-24